跳至主要内容
临床试验/CTRI/2019/10/021553
CTRI/2019/10/021553尚未招募3 期

RIFAXIMIN vs PLACEBO in FUNCTIONAL DYSPEPSIA - A DOUBLE BLIND RANDOMISED CONTROL TRIA

Post Graduate Institute of Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Non-ulcer dyspepsia patients who fulfill epigastric pain syndrome or post-prandial distress syndrome criteria according to the Rome IV Criteria
  • 2. Active dyspeptic symptoms
  • 3. Normal upper endoscopy

排除标准

  • 1. Inability to provide written informed consent
  • 2. No active dyspeptic symptoms
  • 3. Allergic to rifaximin
  • 4. Recent antibiotics use in the past 4 weeks
  • 5. Recent PPI or H2RA in past 4 weeks
  • 6. On anticoagulants, anticonvulsant or oral contraceptives
  • 7. On NSAIDs, aspirin or Clopidogrel, complementary or alternative medicines
  • 8. Pregnancy or breast feeding
  • 9. Previous gastric surgery
  • 10. Dysthyroidism
  • 11. Abnormal liver or kidney function tests
  • 12. Gall stone disease
  • 13. HIV infection
  • 14. Celiac disease
  • 15. Rapid urease test/ antral biopsy for H. pylori positive

研究者

发起方
Post Graduate Institute of Medical Education and Research

相似试验